Physician profile
Xiaohui L Wang
NPI 1982862967
$1,478.83
in general payments reported to CMS, 2019-2025
18 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $112 · 2021: $922 · 2022: $112 · 2023: $120 · 2024: $19.46 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.36 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $198.52 | 2021-2022 | |
| Minerva Surgical, INC | $175.19 | 2025 | |
| Lilly USA, LLC | $168.77 | 2021-2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $133.55 | 2021 | |
| Gilead Sciences, INC. | $111.79 | 2020-2022 | |
| Amgen INC. | $92.33 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $87.78 | 2021-2022 | |
| Novo Nordisk INC | $85.72 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.21 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $71.29 | 2021 | |
| Amarin Pharma, INC. | $62.00 | 2021 | |
| Abbvie INC. | $51.73 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.29 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $32.23 | 2021 | |
| Insmed, INC. | $25.15 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $24.96 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.46 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $15.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiaohui Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.